2025 Showcase Presenters
Andromeda Surgical, Inc.
Andromeda Surgical is building autonomous surgical robots starting with laser enucleation of the prostate (HoLEP/ThuLEP). We use real-time AI guidance and mapping to reduce the learning curve and empower every surgeon to operate at world expert level.
Avlos Medical, LLC.
Avlos Medical, LLC develops halofuginone-coated medical devices to prevent scar and stricture formation without affecting normal tissue healing. Their Phase 0 study showed excellent results for male urethral stricture disease, with no disease recurrence in a small trial, positioning them as leaders in innovative solutions for improved surgical outcomes.
Bot Image AI
Bot Image, Inc. received unique 5-pillar FDA clearance for prostate cancer (PCa) screening, detection, diagnosis, segmentation and classification (with both sliding scale index and PI-RADS scores) of suspect cancer lesions using non-contrast MRI, lending itself as an ideal tool for cognitive fusion biopsy and treatment guidance.
CathConnect
CathConnect is a medical device that improves the safety of urinary catheters by allowing the tube to disconnect when pulled. The device is an independent accessory and can be installed into any urinary catheter.
Contraline
Contraline is a biotechnology company at the forefront of male contraception. Contraline is advancing two revolutionary, clinical-stage products: ADAM, the first long-lasting and reversible vas-occlusive hydrogel implant, as well as NES/T, a transdermal, daily-use hormonal gel.
Dolor Therapeutics
Dolor Therapeutics is a preclinical stage pharmaceutical company from Northwestern University. The primary goal of the company is to develop treatments for high-unmet medical need urologic conditions.
DriQ Health
DriQ Health harnesses AI-powered remote monitoring technology to revolutionize senior care through its innovative, disposable battery-free incontinence detection system. Our comprehensive platform uniquely integrates incontinence monitoring with fall and mobility detection, providing caregivers with real-time insights to enhance the quality of life for seniors while improving operational efficiency in care facilities.
HomeScope
HomeScope is a home cystoscope that captures diagnostic-grade images of the bladder, ensuring accurate detection of lesions and other abnormalities. By allowing patients or non-urologic health care providers to perform remote cystoscopy, HomeScope reduces travel time and costs, improves patient comfort, and expands access to care.
InnoCare Urologics, LLC
InnoCare’s Egress™ Safety Catheter is a urinary safety catheter that automatically deflates if pulled out with the balloon inflated. Pulling forces activate a deflation mechanism, deflating the balloon before forced removal. EgressTM is the first device cleared under a new code for “Foley Catheters and Accessories with Additional Safety Features.”
ProArc
ProArc Medical is a clinical-stage startup that has developed a groundbreaking treatment for BPH - a novel transurethral self-embedding prostatic implant. This innovative solution, named "Omega," aims to provide long-lasting relief from BPH while ensuring a simple, safe, and minimally invasive delivery method.
ProFocal
ProFocalTM is a novel "Cooled Laser Focal Therapy" system that has been specifically designed and engineered to ablate prostate tissue. A single transperineal probe with integrated cooling and dual temperature sensors provides a safe, reliable and highly accurate ablation. The fast and precision control of energy enables reliable and reproducible prostate ablations without adverse outcomes commonly seen with other focal therapy systems.
PS Fertility, Inc.
PS Fertility provides innovative male fertility diagnostic tests that have the power to significantly change fertility treatment by detecting whether sperm is capable of fertilization.
Vesica Health, Inc.
Vesica Health's mission is to improve the early detection of bladder cancer with its clinically validated, noninvasive, urine-based AssureMDx test, which identifies high-risk hematuria patients for timely referral to urology for clinical evaluation. Backed by experienced leadership and a clear path to market adoption, Vesica offers investors a unique opportunity to drive innovation in precision oncology and significantly enhance patient outcomes.
Verve Medical
Verve Medical is an early-stage medical device company focused on the treatment of hypertension. Verve’s unique urological transurethral approach targets and treats the nerves responsible for hypertension, at the source, within the renal pelvis of the kidney with RF ablation.